摘要
目的 ：探讨卵巢子宫内膜异位症与卵巢恶性肿瘤的相关性。方法 ：对2011年8月-2014年9月期间我院收治的94例卵巢恶性肿瘤患者的临床资料进行回顾性研究。我们将未合并卵巢子宫内膜异位症的患者设为观察组,将合并卵巢子宫内膜异位症的患者设为对照组。对两组患者进行病理检查,比较两组患者进行病理检查的结果。结果 ：观察组患者中Ⅰ期卵巢恶性肿瘤患者所占比例明显低于对照组患者,二者相比差异具有显著性（P〈0.05）。在观察组患者中,Ⅲ期卵巢恶性肿瘤患者所占比例明显高于对照组患者,二者相比差异具有显著性（P〈0.05）。在观察组患者中,透明细胞癌患者所占比例明显低于对照组患者,二者相比差异具有显著性（P〈0.05）。结论：卵巢子宫内膜异位症对卵巢恶性肿瘤的病理分期、病理组织类型有明显的影响,卵巢恶性肿瘤合并卵巢子宫内膜异位症患者的主要病理特征为其卵巢内存在透明细胞癌。
Objective To study the correlation between ovarian endometriosis and malignant tumor. Methods 94 cases of patients with malignant ovarian tumor admitted into the hospital in recent years were taken as the study samples. Patients without complicated ovarian endometriosis were taken as group A while with as group B. The pathological features of the two groups of patients were comparatively analyzed. Results In group A, patients in stage I accounted for 30.43% which was significantly lower than 70.83% in the control group; Patients in stage III accounted for 56.52% which was significantly higher than 20.83% in the control group anf the differences were significant（P〈 0.05）; Clear cell carcinoma in group A accounted for 4.35% which was significantly lower than 20.83% in the control group（P〈 0.05）. Differences in other pathological types were not statistically significant（P 〉0.05）. Conclusion Ovarian endometriosis has a significant effect on pathological staging and pathological types of malignant tumors, and the clear cell carcinoma in stage Ⅲ is the main manifestation of malignant tumor and endometriosis.
